Dexcom gains FDA approval; stocks rise

June 4, 2014 12:58 AM

7 0

Share prices in San Diego's Dexcom Inc. rose nearly 6 percent in after-hours trading Tuesday after the company announced it had received FDA approval for a new system aimed at providing diabetic patients and their doctors with real-time information about their sugar levels.

Dexcom (Nasdaq: DXCM) shares, which tumbled sharply during March and April, have been moving higher over the past month, partly spurred by MSNBC and stock commentator Jim Cramer, who said that the company's continuous glucose monitoring systems — which monitor the sugars in the body wi...

Also read: New FCC Rules Require Internet Providers to Protect Users’ Personal Information

Read more

To category page